Ageas N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
02 nov 2006 - 12:31
Statutaire naam
Ageas N.V.
Titel
Fortis Private Equity acquires Innovative Medical Solutions
Bericht
Fortis Private Equity has acquired all shares in Dutch-based Innovative Medical Solutions BV (IMS) together with the company’s management team.
IMS is a leading European developer and worldwide supplier of branded medical and wellness products. Its brands have enjoyed an excellent reputation for more than 30 years and are distributed in over 70 countries. The operations are conducted from the Benelux countries and Germany and are grouped under GymnaUniphy (Bilzen) and Uniphy Elektromedizin (Berlin).
GymnaUniphy and Uniphy Elektromedizin offer a complete range of medical equipment (physiotherapy and rehabilitation markets) and wellness devices (fitness, professional sports and beauty markets). Their products include treatment couches, and electrotherapy, ultrasound, vibration, laser and thermotherapy equipment and are sold under the well-known brand names Gymna, Uniphy, FitVibe and ShockMaster.
Product innovation and international sales and marketing are the core activities of the IMS group. The company has a worldwide reputation for top quality and added value in its segment.
Rob Vliek, CEO of IMS says: “IMS is well positioned to respond to trends such as increasing obesity, population ageing, and a growing awareness of illness prevention and wellbeing. Our new partnership with Fortis Private Equity will support our ambitious growth strategy and give us the financial scope to continue to play a role as a key supplier of innovative and high-quality products. To strengthen our market position we need to continuously invest in research and development and extend our distribution channels. I am delighted we have been able to team up with such a strong financial partner as Fortis.”
Brigitte Boone, CEO Fortis Private Equity & Structured Finance, adds: “The management buy-out of IMS illustrates our investment strategy of focusing on successful medium-sized enterprises that boast market leadership, healthy growth perspectives and committed management teams. IMS is an
Datum laatste update: 27 maart 2025